Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease
Heftet /
2010
/ Engelsk
Produktdetaljer
ISBN
9780309151290
Publisert
2010-07-25
Utgiver
Vendor
National Academies Press
Høyde
229 mm
Bredde
152 mm
Aldersnivå
P, 06
Språk
Product language
Engelsk
Format
Product format
Heftet
Antall sider
334
Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process.
Les mer
1 Front Matter; 2 Summary; 3 1 Introduction; 4 2 Review: Evaluating and Regulating Biomarker Use; 5 3 The Biomarker Evaluation Process; 6 4 Case Studies; 7 5 Strengthening Evidence-Based Regulation; 8 Acronyms; 9 Glossary; 10 Appendix A: Table of Papers About Biomarker Qualification; 11 Appendix B: Recommendations from Related IOM Reports; 12 Appendix C: Committee Member and Consultant Biographies; 13 Appendix D: Staff Biographies; 14 Appendix E: Workshop Agenda; 15 Appendix F: Speaker Biographies
Les mer
Produktdetaljer
ISBN
9780309151290
Publisert
2010-07-25
Utgiver
Vendor
National Academies Press
Høyde
229 mm
Bredde
152 mm
Aldersnivå
P, 06
Språk
Product language
Engelsk
Format
Product format
Heftet
Antall sider
334